查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1362927

口乾症治療藥物市場規模、佔有率、趨勢分析報告：按類型、按產品、地區和細分市場預測，2023-2030

Xerostomia Therapeutics Market Size, Share & Trends Analysis Report By Type (OTC, Prescription), By Product (Salivary Stimulants, Salivary Substitutes, Dentifrices), By Region, And Segment Forecasts, 2023 - 2030
出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10個工作天內

價格

口乾症治療市場的成長與趨勢：

Grand View Research, Inc.最新報告顯示，2023年至2030年，全球口乾症治療市場規模預計將以3.8%的年複合成長率成長，2030年達到27億美元。

口乾症產品優惠報銷政策的增加和對相關疾病的認知不斷提高是推動市場成長的主要要素。

此外，口乾症和乾燥症候群、糖尿病、高血壓和帕金森氏症等相關疾病的患病，對整個市場產生了積極影響。據高露潔棕欖稱，美國有 2500 萬人患有口乾症。據美國乾燥綜合症基金會稱，大約有 400 萬美國人患有乾燥症候群，這是一種自體免疫疾病。

提高對口乾症及相關疾病意識的措施預計將推動成長。例如，美國乾燥症候群基金會在美國和加拿大開展提高意識計劃，以幫助患有症候群的患者。 2012年，基金會推出了5年突破目標，旨在2017年將該症候群的診斷時間縮短至2.5年以內。

此外，領先公司正專注於收購新興企業並實施計劃，以提高對口乾症狀的認知。例如，Church &Dwight Co., Inc. 旗下品牌 Orajel 與數位行銷機構 iCrossing 合作，發起了一項活動，教育家長了解口腔清潔用品的重要性。

口乾症治療藥物市場報告亮點

  • 預計到2022年，口乾症藥物的全球市場規模將達到20億美元，預計2023年至2030年年複合成長率為3.8%。
  • 由於可用性、可負擔性和高效率要素，OTC 領域在市場上佔據主導地位。
  • 預計牙科用細分市場在預測期內將以最快的年複合成長率成長。
  • 由於導致口乾的疾病患病不斷上升以及意識提升的舉措不斷增加等要素，北美在 2022 年佔據了最大佔有率。
  • 由於人們對該疾病的認知不斷提高以及醫療保健支出不斷增加，預計亞太地區在未來年度將出現良好的成長。
  • 葛蘭素史克、Church & Dwight 和高露潔棕欖等主要企業主導全球口乾症藥物市場。

目錄

第1章 調查方法和範圍

第2章 執行摘要

第3章 .口乾症治療藥物市場的變數、趨勢與範圍

  • 市場體系預測
    • 母市場預測
    • 相關/附隨市場預測
  • 普及和成長預測圖
  • 市場動態
    • 市場促進因素分析
    • 市場抑制因素分析
  • 口乾症治療藥物市場分析工具
    • 產業分析-波特五力分析
    • PESTEL分析

第4章 口乾症治療藥物：種類估算及趨勢分析

  • 口乾症治療藥物市場：重點
  • 口乾症治療藥物市場：2022 年和 2030 年趨勢和市場佔有率分析
  • 店面銷售(OTC)
    • 在商店
  • 處方箋
    • 2018年至2030年處方箋市場估計與預測

第5章 口乾症治療藥物：產品估算與趨勢分析

  • 口乾症治療藥物市場：重點
  • 口乾症治療藥物市場：2022 年和 2030 年趨勢和市場佔有率分析
  • 唾液分泌興奮劑
  • 唾液替代
  • 牙膏

第6章 口乾症治療藥物市場：區域估計與趨勢分析

  • 區域預測
  • 口乾症治療藥物系統市場：按地區分類的主要市場點
  • 北美洲
    • 2018-2030 年市場估計與預測
    • 美國
    • 加拿大
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 瑞典
    • 挪威
    • 丹麥
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 澳洲
    • 泰國
    • 韓國
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中東/非洲
    • 沙烏地阿拉伯
    • 南非
    • 阿拉伯聯合大公國
    • 科威特

第7章 競爭形勢

  • 主要市場參與企業的最新趨勢和影響分析
  • 市場參與企業分類
    • Acacia Pharma
    • Parnell Pharmaceuticals, Inc.
    • Pfizer, Inc.
    • GlaxoSmithKline plc
    • Church & Dwight Co., Inc.
    • Lupin
    • Sun Pharmaceutical Industries, Ltd.
    • Hikma Pharmaceuticals PLC
    • Pendopharm
    • OraCoat
Product Code: GVR-1-68038-628-8

Xerostomia Therapeutics Market Growth & Trends:

The global xerostomia therapeutics market size is expected to reach USD 2.70 billion by 2030, expanding at a CAGR of 3.8% from 2023 to 2030, according to a new report by Grand View Research, Inc.. Increase in favorable reimbursement policies for xerostomia products and growing awareness about associated diseases are the major factors contributing toward market growth.

In addition, increasing prevalence of xerostomia and associated diseases such as Sjogren's syndrome, diabetes, hypertension, and Parkinson's disease has a positive impact on the overall market. According to Colgate-Palmolive Company, 25 million people in the U.S. experience dry mouth. According to Sjogren Syndrome Foundation of America, around 4 million Americans are suffering from Sjogren's syndrome, an autoimmune disorder.

Growing initiatives for raising awareness about xerostomia and associated diseases are expected to drive growth. For instance, Sjogren Syndrome Foundation of America conducts awareness programs and supports patients suffering from the syndrome in the U.S. and Canada. In 2012, the foundation launched the "5-Year Breakthrough Goal" with an aim to reduce the time required to diagnose the condition to less than 2.5 years by 2017.

Furthermore, major players focus on acquiring emerging companies and conduct programs to raise awareness about dry mouth condition. For instance, Orajel, a brand of Church & Dwight Co., Inc. initiated a campaign with the help of iCrossing, a digital marketing agency to educate parents about the importance of oral care.

Xerostomia Therapeutics Market Report Highlights:

  • The global xerostomia therapeutics market size was estimated at USD 2.0 billion in 2022 and is expected to grow with CAGR of 3.8% from 2023 to 2030
  • The OTC segment dominated the market due to factors such as ease in availability, affordability, and higher efficiency
  • The dentifrices segment is expected to grow at the fastest CAGR over the forecast period.
  • North America held the largest share in 2022 owing to factors such as increasing prevalence of diseases resulting in dry mouth and growing initiatives for raising awareness about xerostomia
  • The Asia Pacific region is anticipated to witness lucrative growth over the next decade due to increasing awareness of the disease and growing healthcare expenditure
  • Some of the key players such as GlaxoSmithKline plc; Church & Dwight Co., Inc.; and Colgate-Palmolive Company dominated the global xerostomia therapeutics market

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Type
    • 1.1.2. Product
    • 1.1.3. Regional scope
    • 1.1.4. Estimates and forecast timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
  • 1.4. Information or Data Analysis
    • 1.4.1. Data analysis models
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Product outlook
    • 2.2.2. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Xerostomia Therapeutics Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Market Dynamics
    • 3.3.1. Market driver analysis
    • 3.3.2. Market restraint analysis
  • 3.4. Xerostomia Therapeutics Market Analysis Tools
    • 3.4.1. Industry analysis - Porter's
      • 3.4.1.1. Supplier power
      • 3.4.1.2. Buyer power
      • 3.4.1.3. Substitution threat
      • 3.4.1.4. Threat of new entrant
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Technological landscape
      • 3.4.2.3. Economic landscape

Chapter 4. Xerostomia Therapeutics: Type Estimates & Trend Analysis

  • 4.1. Xerostomia Therapeutics Market: Key Takeaways
  • 4.2. Xerostomia Therapeutics Market: Movement & Market Share Analysis, 2022 & 2030
  • 4.3. Over-the-counter (OTC)
    • 4.3.1. Over-the-counter (OTC) market estimates and forecast 2018 to 2030 (USD million)
  • 4.4. Prescription
    • 4.4.1. Prescription market estimates and forecast 2018 to 2030 (USD million)

Chapter 5. Xerostomia Therapeutics: Product Estimates & Trend Analysis

  • 5.1. Xerostomia Therapeutics Market: Key Takeaways
  • 5.2. Xerostomia Therapeutics Market: Movement & Market Share Analysis, 2022 & 2030
  • 5.3. Salivary Stimulants
    • 5.3.1. Salivary stimulants market estimates and forecast 2018 to 2030 (USD million)
  • 5.4. Salivary Substitutes
    • 5.4.1. Salivary substitutes market estimates and forecast 2018 to 2030 (USD Million)
  • 5.5. Dentifrices
    • 5.5.1. Dentifrices market estimates and forecast 2018 to 2030 (USD million)

Chapter 6. Xerostomia Therapeutics Market: Regional Estimates & Trend Analysis

  • 6.1. Regional Outlook
  • 6.2. Xerostomia Therapeutics System Market by Region: Key Marketplace Takeaway
  • 6.3. North America
    • 6.3.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
    • 6.3.2. U.S.
      • 6.3.2.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
    • 6.3.3. Canada
      • 6.3.3.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
  • 6.4. Europe
    • 6.4.1. UK
      • 6.4.1.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
    • 6.4.2. Germany
      • 6.4.2.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
    • 6.4.3. France
      • 6.4.3.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
    • 6.4.4. Italy
      • 6.4.4.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
    • 6.4.5. Spain
      • 6.4.5.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
    • 6.4.6. Sweden
      • 6.4.6.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
    • 6.4.7. Norway
      • 6.4.7.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
    • 6.4.8. Denmark
      • 6.4.8.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
  • 6.5. Asia Pacific
    • 6.5.1. China
      • 6.5.1.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
    • 6.5.2. Japan
      • 6.5.2.1. Market estimates and forecast, 2018 - 2030 (Volume, Thousand)
    • 6.5.3. India
      • 6.5.3.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
    • 6.5.4. Australia
      • 6.5.4.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
    • 6.5.5. Thailand
      • 6.5.5.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
    • 6.5.6. South Korea
      • 6.5.6.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
  • 6.6. Latin America
    • 6.6.1. Brazil
      • 6.6.1.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
    • 6.6.2. Mexico
      • 6.6.2.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
    • 6.6.3. Argentina
      • 6.6.3.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
  • 6.7. MEA
    • 6.7.1. Saudi Arabia
      • 6.7.1.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
    • 6.7.2. South Africa
      • 6.7.2.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
    • 6.7.3. UAE
      • 6.7.3.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
    • 6.7.4. Kuwait
      • 6.7.4.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 7.2. Market Participant Categorization
    • 7.2.1. Acacia Pharma
      • 7.2.1.1. Company overview
      • 7.2.1.2. Financial performance
      • 7.2.1.3. Type benchmarking
      • 7.2.1.4. Strategic initiatives
    • 7.2.2. Parnell Pharmaceuticals, Inc.
      • 7.2.2.1. Company overview
      • 7.2.2.2. Financial performance
      • 7.2.2.3. Type benchmarking
      • 7.2.2.4. Strategic initiatives
    • 7.2.3. Pfizer, Inc.
      • 7.2.3.1. Company overview
      • 7.2.3.2. Financial performance
      • 7.2.3.3. Type benchmarking
      • 7.2.3.4. Strategic initiatives
    • 7.2.4. GlaxoSmithKline plc
      • 7.2.4.1. Company overview
      • 7.2.4.2. Financial performance
      • 7.2.4.3. Type benchmarking
      • 7.2.4.4. Strategic initiatives
    • 7.2.5. Church & Dwight Co., Inc.
      • 7.2.5.1. Company overview
      • 7.2.5.2. Financial performance
      • 7.2.5.3. Type benchmarking
      • 7.2.5.4. Strategic initiatives
    • 7.2.6. Lupin
      • 7.2.6.1. Company overview
      • 7.2.6.2. Financial performance
      • 7.2.6.3. Type benchmarking
      • 7.2.6.4. Strategic initiatives
    • 7.2.7. Sun Pharmaceutical Industries, Ltd.
      • 7.2.7.1. Company overview
      • 7.2.7.2. Financial performance
      • 7.2.7.3. Type benchmarking
      • 7.2.7.4. Strategic initiatives
    • 7.2.8. Hikma Pharmaceuticals PLC
      • 7.2.8.1. Company overview
      • 7.2.8.2. Financial performance
      • 7.2.8.3. Type benchmarking
      • 7.2.8.4. Strategic initiatives
    • 7.2.9. Pendopharm
      • 7.2.9.1. Company overview
      • 7.2.9.2. Financial performance
      • 7.2.9.3. Type benchmarking
      • 7.2.9.4. Strategic initiatives
    • 7.2.10. OraCoat
      • 7.2.10.1. Company overview
      • 7.2.10.2. Financial performance
      • 7.2.10.3. Type benchmarking
      • 7.2.10.4. Strategic initiatives

List of Tables

  • Table 1 List of Abbreviations
  • Table 2 North America xerostomia therapeutics market, by type, 2018 - 2030 (USD Million)
  • Table 3 North America xerostomia therapeutics market, by product, 2018 - 2030 (USD Million)
  • Table 4 North America xerostomia therapeutics market, by region, 2018 - 2030 (USD Million)
  • Table 5 U.S. xerostomia therapeutics market, by type, 2018 - 2030 (USD Million)
  • Table 6 U.S. xerostomia therapeutics market, by product, 2018 - 2030 (USD Million)
  • Table 7 Canada xerostomia therapeutics market, by type, 2018 - 2030 (USD Million)
  • Table 8 Canada xerostomia therapeutics market, by product, 2018 - 2030 (USD Million)
  • Table 9 Europe xerostomia therapeutics market, by type, 2018 - 2030 (USD Million)
  • Table 10 Europe xerostomia therapeutics market, by product, 2018 - 2030 (USD Million)
  • Table 11 Europe xerostomia therapeutics market, by region, 2018 - 2030 (USD Million)
  • Table 12 Germany xerostomia therapeutics market, by type, 2018 - 2030 (USD Million)
  • Table 13 Germany xerostomia therapeutics market, by product, 2018 - 2030 (USD Million)
  • Table 14 UK xerostomia therapeutics market, by type, 2018 - 2030 (USD Million)
  • Table 15 UK xerostomia therapeutics market, by product, 2018 - 2030 (USD Million)
  • Table 16 France xerostomia therapeutics market, by type, 2018 - 2030 (USD Million)
  • Table 17 France xerostomia therapeutics market, by product, 2018 - 2030 (USD Million)
  • Table 18 Italy xerostomia therapeutics market, by type, 2018 - 2030 (USD Million)
  • Table 19 Italy xerostomia therapeutics market, by product, 2018 - 2030 (USD Million)
  • Table 20 Spain xerostomia therapeutics market, by type, 2018 - 2030 (USD Million)
  • Table 21 Spain xerostomia therapeutics market, by product, 2018 - 2030 (USD Million)
  • Table 22 Sweden xerostomia therapeutics market, by type, 2018 - 2030 (USD Million)
  • Table 23 Sweden xerostomia therapeutics market, by product, 2018 - 2030 (USD Million)
  • Table 24 Norway xerostomia therapeutics market, by type, 2018 - 2030 (USD Million)
  • Table 25 Norway xerostomia therapeutics market, by product, 2018 - 2030 (USD Million)
  • Table 26 Denmark xerostomia therapeutics market, by type, 2018 - 2030 (USD Million)
  • Table 27 Denmark xerostomia therapeutics market, by product, 2018 - 2030 (USD Million)
  • Table 28 APAC xerostomia therapeutics market, by type, 2018 - 2030 (USD Million)
  • Table 29 APAC xerostomia therapeutics market, by product, 2018 - 2030 (USD Million)
  • Table 30 APAC xerostomia therapeutics market, by region, 2018 - 2030 (USD Million)
  • Table 31 Japan xerostomia therapeutics market, by type, 2018 - 2030 (USD Million)
  • Table 32 Japan xerostomia therapeutics market, by product, 2018 - 2030 (USD Million)
  • Table 33 China xerostomia therapeutics market, by type, 2018 - 2030 (USD Million)
  • Table 34 China xerostomia therapeutics market, by product, 2018 - 2030 (USD Million)
  • Table 35 India xerostomia therapeutics market, by type, 2018 - 2030 (USD Million)
  • Table 36 India xerostomia therapeutics market, by product, 2018 - 2030 (USD Million)
  • Table 37 Australia xerostomia therapeutics market, by type, 2018 - 2030 (USD Million)
  • Table 38 Australia xerostomia therapeutics market, by product, 2018 - 2030 (USD Million)
  • Table 39 Thailand xerostomia therapeutics market, by type, 2018 - 2030 (USD Million)
  • Table 40 Thailand xerostomia therapeutics market, by product, 2018 - 2030 (USD Million)
  • Table 41 South Korea xerostomia therapeutics market, by type, 2018 - 2030 (USD Million)
  • Table 42 South Korea xerostomia therapeutics market, by product, 2018 - 2030 (USD Million)
  • Table 43 Latin America xerostomia therapeutics market, by type, 2018 - 2030 (USD Million)
  • Table 44 Latin America xerostomia therapeutics market, by product, 2018 - 2030 (USD Million)
  • Table 45 Latin America xerostomia therapeutics market, by region, 2018 - 2030 (USD Million)
  • Table 46 Brazil xerostomia therapeutics market, by type, 2018 - 2030 (USD Million)
  • Table 47 Brazil xerostomia therapeutics market, by product, 2018 - 2030 (USD Million)
  • Table 48 Mexico xerostomia therapeutics market, by type, 2018 - 2030 (USD Million)
  • Table 49 Mexico xerostomia therapeutics market, by product, 2018 - 2030 (USD Million)
  • Table 50 Argentina xerostomia therapeutics market, by type, 2018 - 2030 (USD Million)
  • Table 51 Argentina xerostomia therapeutics market, by product, 2018 - 2030 (USD Million)
  • Table 52 Middle East and Africa xerostomia therapeutics market, by type, 2018 - 2030 (USD Million)
  • Table 53 Middle East and Africa xerostomia therapeutics market, by product, 2018 - 2030 (USD Million)
  • Table 54 Middle East and Africa xerostomia therapeutics market, by region, 2018 - 2030 (USD Million)
  • Table 55 South Africa xerostomia therapeutics market, by type, 2018 - 2030 (USD Million)
  • Table 56 South Africa xerostomia therapeutics market, by product, 2018 - 2030 (USD Million)
  • Table 57 Saudi Arabia xerostomia therapeutics market, by type, 2018 - 2030 (USD Million)
  • Table 58 Saudi Arabia xerostomia therapeutics market, by product, 2018 - 2030 (USD Million)
  • Table 59 UAE xerostomia therapeutics market, by type, 2018 - 2030 (USD Million)
  • Table 60 UAE xerostomia therapeutics market, by product, 2018 - 2030 (USD Million)
  • Table 61 Kuwait xerostomia therapeutics market, by type, 2018 - 2030 (USD Million)
  • Table 62 Kuwait xerostomia therapeutics market, by product, 2018 - 2030 (USD Million)

List of Figure

Fig. 1 Market research process

Fig. 2 Data triangulation techniques

Fig. 3 Primary research pattern

Fig. 4 Market research approaches

Fig. 5 Value-chain-based sizing & forecasting

Fig. 6 QFD modeling for market share assessment

Fig. 7 Market formulation & validation

Fig. 8 Xerostomia therapeutics: market outlook

Fig. 9 Xerostomia therapeutics competitive insights

Fig. 10 Parent market outlook

Fig. 11 Related/ancillary market outlook

Fig. 12 Penetration and growth prospect mapping

Fig. 13 Industry value chain analysis

Fig. 14 Xerostomia therapeutics market driver impact

Fig. 15 Xerostomia therapeutics market restraint impact

Fig. 16 Xerostomia therapeutics market strategic initiatives analysis

Fig. 17 Xerostomia therapeutics market: type movement analysis

Fig. 18 Xerostomia therapeutics market: type outlook and key takeaways

Fig. 19 Over-the-counter (OTC) market estimates and forecast, 2018 - 2030 (USD Million)

Fig. 20 Prescription market estimates and forecast, 2018 - 2030 (USD Million)

Fig. 21 Xerostomia therapeutics market: product movement analysis

Fig. 22 Xerostomia therapeutics market: product outlook and key takeaways

Fig. 23 Salivary stimulants market estimates and forecast, 2018 - 2030 (USD Million)

Fig. 24 Salivary substitutes market estimates and forecast, 2018 - 2030 (USD Million)

Fig. 25 Dentifrices market estimates and forecast, 2018 - 2030 (USD Million)

Fig. 26 Xerostomia therapeutics market: material movement analysis

Fig. 27 Global xerostomia therapeutics market: regional movement analysis

Fig. 28 Global xerostomia therapeutics market: regional outlook and key takeaways

Fig. 29 North America, by country

Fig. 30 North America market estimates and forecast, 2018 - 2030 (USD Million)

Fig. 31 U.S. market estimates and forecast, 2018 - 2030 (USD Million)

Fig. 32 Canada market estimates and forecast, 2018 - 2030 (USD Million)

Fig. 33 Europe. market estimates and forecast, 2018 - 2030 (USD Million)

Fig. 34 UK market estimates and forecast, 2018 - 2030 (USD Million)

Fig. 35 Germany market estimates and forecast, 2018 - 2030 (USD Million)

Fig. 36 France market estimates and forecast, 2018 - 2030 (USD Million)

Fig. 37 Italy market estimates and forecast, 2018 - 2030 (USD Million)

Fig. 38 Spain market estimates and forecast, 2018 - 2030 (USD Million)

Fig. 39 Sweden market estimates and forecast, 2018 - 2030 (USD Million)

Fig. 40 Norway market estimates and forecast, 2018 - 2030 (USD Million)

Fig. 41 Denmark market estimates and forecast, 2018 - 2030 (USD Million)

Fig. 42 Asia Pacific market estimates and forecast, 2018 - 2030 (USD Million)

Fig. 43 China market estimates and forecast, 2018 - 2030 (USD Million)

Fig. 44 Japan market estimates and forecast, 2018 - 2030 (USD Million)

Fig. 45 India market estimates and forecast, 2018 - 2030 (USD Million)

Fig. 46 Australia market estimates and forecast, 2018 - 2030 (USD Million)

Fig. 47 Thailand market estimates and forecast, 2018 - 2030 (USD Million)

Fig. 48 South Korea market estimates and forecast, 2018 - 2030 (USD Million)

Fig. 49 Latin America market estimates and forecast, 2018 - 2030 (USD Million)

Fig. 50 Brazil market estimates and forecast, 2018 - 2030 (USD Million)

Fig. 51 Mexico market estimates and forecast, 2018 - 2030 (USD Million)

Fig. 52 Argentina market estimates and forecast, 2018 - 2030 (USD Million)

Fig. 53 Middle East and Africa. market estimates and forecast, 2018 - 2030 (USD Million)

Fig. 54 Saudi Arabia market estimates and forecast, 2018 - 2030 (USD Million)

Fig. 55 South Africa market estimates and forecast, 2018 - 2030 (USD Million)

Fig. 56 UAE market estimates and forecast, 2018 - 2030 (USD Million)

Fig. 57 Kuwait market estimates and forecast, 2018 - 2030 (USD Million)